MCL Clinical Trials
1230 trials from ClinicalTrials.gov. Recruiting trials shown first.
BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma
UNKNOWNNCT00039156·PHASE2·Theradex
ortataxel
VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma
COMPLETEDNCT00036946·PHASE1·Regeneron Pharmaceuticals
ziv-aflibercept
Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies
COMPLETEDNCT00040846·PHASE2·Fred Hutchinson Cancer Center·60 enrolled
alemtuzumabfludarabine phosphatetotal-body irradiationallogeneic hematopoietic stem cell transplantationperipheral blood stem cell transplantation+2 more
Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma
COMPLETEDNCT00047021·PHASE2·Case Comprehensive Cancer Center·3 enrolled
sargramostimcytarabinemitoxantrone hydrochloride
Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
COMPLETEDNCT00026182·PHASE2·National Cancer Institute (NCI)·99 enrolled
rituximabrecombinant interleukin-12laboratory biomarker analysisquestionnaire administrationquality-of-life assessment
Nonmyeloablative Allogeneic Transplant
COMPLETEDNCT01272817·NA·Scripps Health·36 enrolled
Nonmyeloablative Allogeneic TransplantNonmyeloablative Allogeneic Transplant
Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia
UNKNOWNNCT00020865·PHASE3·Jonsson Comprehensive Cancer Center
cefepime hydrochloridelevofloxacin
Phase 1/2 Study of VSLI Plus Rituximab in Patients With Relapsed and/or Refractory NHL
COMPLETEDNCT01851551·PHASE1 / PHASE2·Acrotech Biopharma Inc.·22 enrolled
Vincristine Sulfate Liposome Injection plus rituximab
Combination Antibody Therapy for Relapsed Lymphoma and Chronic Lymphocytic Leukemia
TERMINATEDNCT00022971·PHASE1·National Cancer Institute (NCI)·35 enrolled
ApolizumabRituximab
Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma
COMPLETEDNCT00027937·PHASE2·Fred Hutchinson Cancer Center
aldesleukinfilgrastimsargramostimbusulfancyclophosphamide+5 more
Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction
COMPLETEDNCT00025415·PHASE1·National Cancer Institute (NCI)·60 enrolled
imatinib mesylatepharmacological study
Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
COMPLETEDNCT00027560·PHASE2·Memorial Sloan Kettering Cancer Center·51 enrolled
alemtuzumabcyclosporinefludarabine phosphatemelphalanallogeneic bone marrow transplantation+1 more
Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma
COMPLETEDNCT00992992·PHASE2·GlaxoSmithKline·25 enrolled
Tositumomab and Iodine I 131 Tositumomab followed by CHOP
Bortezomib in Treating Patients With Lymphoproliferative Disorders
COMPLETEDNCT00023764·PHASE2·National Cancer Institute (NCI)·103 enrolled
bortezomib
Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma
COMPLETEDNCT00020943·PHASE2·Alliance for Clinical Trials in Oncology·79 enrolled
filgrastimrituximabcarmustinecyclophosphamidecytarabine+7 more
Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
COMPLETEDNCT00161187·PHASE1·University of Medicine and Dentistry of New Jersey·37 enrolled
therapeutic allogeneic lymphocytes
Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS
COMPLETEDNCT00025662·PHASE2·National Heart, Lung, and Blood Institute (NHLBI)·23 enrolled
RFT5-SMPT-dgAIsolex system
Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer
COMPLETEDNCT00237627·PHASE1 / PHASE2·UNC Lineberger Comprehensive Cancer Center·107 enrolled
PS-341DoxilVelcade
HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma
COMPLETEDNCT00144092·PHASE2·Alberta Health services·60 enrolled
stem cell source
Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer
COMPLETEDNCT00290641·NA·Masonic Cancer Center, University of Minnesota·68 enrolled
filgrastimgraft-versus-tumor induction therapycyclophosphamidecyclosporinefludarabine phosphate+3 more
S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma
COMPLETEDNCT00016094·PHASE2·National Cancer Institute (NCI)·60 enrolled
bevacizumablaboratory biomarker analysis
Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma
COMPLETEDNCT00017381·EARLY_PHASE1·National Cancer Institute (NCI)·30 enrolled
rituximabcyclophosphamidefilgrastimyttrium Y 90 ibritumomab tiuxetanperipheral blood stem cell transplantation
Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma
UNKNOWNNCT00009776·PHASE1·University of California, Davis
monoclonal antibody Lym-1cyclosporinepaclitaxelindium In 111 monoclonal antibody Lym-1yttrium Y 90 monoclonal antibody Lym-1
VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas
COMPLETEDNCT00025129·PHASE1·Vion Pharmaceuticals
laromustine
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
COMPLETEDNCT00020579·PHASE1·National Institutes of Health Clinical Center (CC)·75 enrolled
entinostat
Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
UNKNOWNNCT00028717·PHASE3·Commissie Voor Klinisch Toegepast Onderzoek·400 enrolled
filgrastimrituximabcyclophosphamidedoxorubicin hydrochlorideprednisone+1 more
Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma
COMPLETEDNCT00006252·PHASE2·Cancer and Leukemia Group B·47 enrolled
fludarabine phosphateCyclophosphamidePBSCG-CSFDonor lymphocytes
Monoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma
UNKNOWNNCT00008021·PHASE1·University of California, Davis
filgrastimmonoclonal antibody Lym-1cyclosporinepaclitaxelperipheral blood stem cell transplantation+2 more
Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma
UNKNOWNNCT00026429·PHASE2·Pharmatech Oncology
denileukin diftitox
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
COMPLETEDNCT00052936·PHASE3·German High-Grade Non-Hodgkin's Lymphoma Study Group·1506 enrolled
filgrastimrituximabCHOP regimencyclophosphamidedoxorubicin hydrochloride+3 more